Sunflower Pharmaceutical GroupLtd Balance Sheet Health
Financial Health criteria checks 6/6
Sunflower Pharmaceutical GroupLtd has a total shareholder equity of CN¥5.3B and total debt of CN¥13.7M, which brings its debt-to-equity ratio to 0.3%. Its total assets and total liabilities are CN¥7.1B and CN¥1.9B respectively. Sunflower Pharmaceutical GroupLtd's EBIT is CN¥978.3M making its interest coverage ratio -11.2. It has cash and short-term investments of CN¥3.8B.
Key information
0.3%
Debt to equity ratio
CN¥13.70m
Debt
Interest coverage ratio | -11.2x |
Cash | CN¥3.80b |
Equity | CN¥5.28b |
Total liabilities | CN¥1.87b |
Total assets | CN¥7.15b |
Recent financial health updates
No updates
Recent updates
Sunflower Pharmaceutical GroupLtd's (SZSE:002737) Shareholders Will Receive A Bigger Dividend Than Last Year
Jun 07Earnings Troubles May Signal Larger Issues for Sunflower Pharmaceutical GroupLtd (SZSE:002737) Shareholders
May 06Sunflower Pharmaceutical Group Co.,Ltd's (SZSE:002737) Subdued P/E Might Signal An Opportunity
Apr 16We Ran A Stock Scan For Earnings Growth And Sunflower Pharmaceutical GroupLtd (SZSE:002737) Passed With Ease
Mar 04Financial Position Analysis
Short Term Liabilities: 002737's short term assets (CN¥5.1B) exceed its short term liabilities (CN¥1.5B).
Long Term Liabilities: 002737's short term assets (CN¥5.1B) exceed its long term liabilities (CN¥352.8M).
Debt to Equity History and Analysis
Debt Level: 002737 has more cash than its total debt.
Reducing Debt: 002737's debt to equity ratio has reduced from 15.4% to 0.3% over the past 5 years.
Debt Coverage: 002737's debt is well covered by operating cash flow (6167.5%).
Interest Coverage: 002737 earns more interest than it pays, so coverage of interest payments is not a concern.